Molndal, Sweden

Kaj Blennow

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 3.9

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Gothenburg, SE (2011)
  • Molndal, SE (2010 - 2019)

Company Filing History:


Years Active: 2010-2019

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Kaj Blennow: Innovator in Neurodegenerative Disease Diagnostics

Introduction

Kaj Blennow is a prominent inventor based in Molndal, Sweden. He has made significant contributions to the field of neurodegenerative disease diagnostics. With a total of 5 patents, his work focuses on innovative methods for detecting conditions such as Alzheimer's disease and Parkinson's disease.

Latest Patents

Kaj Blennow's latest patents include a diagnostic method for Parkinson's disease and Lewy body dementia. This method involves detecting the presence of fragments of a marker protein in the brain of a patient. The process includes providing a sample of macrophages obtained from the patient and identifying abnormal levels of the marker protein, which can indicate the presence of the condition. His second patent is a diagnostic method for Alzheimer's disease, which follows a similar approach in detecting marker proteins associated with the disease.

Career Highlights

Throughout his career, Kaj Blennow has worked with notable companies such as Inven2 AS and Vermillion, Inc. His expertise in the field has led to advancements in diagnostic techniques that are crucial for early detection and monitoring of neurodegenerative diseases.

Collaborations

Kaj has collaborated with esteemed colleagues, including Huw Alun Davies and James Norton McGuire. These partnerships have further enhanced his research and development efforts in the medical field.

Conclusion

Kaj Blennow's innovative work in the diagnosis of neurodegenerative diseases has made a significant impact on medical science. His contributions continue to pave the way for advancements in understanding and treating these complex conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…